Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Maternal obesity in the ewe increases cardiac ventricular expression of glucocorticoid receptors, proinflammatory cytokines and fibrosis in adult male offspring

  • Adel B. Ghnenis,

    Roles Formal analysis, Investigation, Methodology, Writing – original draft, Writing – review & editing

    Affiliation Center for the Study of Fetal Programming, Department of Animal Science, University of Wyoming, Laramie, WY, United States of America

  • John F. Odhiambo,

    Roles Writing – review & editing

    Affiliation Center for the Study of Fetal Programming, Department of Animal Science, University of Wyoming, Laramie, WY, United States of America

  • Richard J. McCormick,

    Roles Investigation

    Affiliation Center for the Study of Fetal Programming, Department of Animal Science, University of Wyoming, Laramie, WY, United States of America

  • Peter W. Nathanielsz,

    Roles Methodology, Supervision, Visualization

    Affiliation Center for the Study of Fetal Programming, Department of Animal Science, University of Wyoming, Laramie, WY, United States of America

  • Stephen P. Ford

    Roles Data curation, Funding acquisition, Investigation, Project administration, Supervision, Validation, Writing – review & editing

    spford@uwyo.edu

    Affiliation Center for the Study of Fetal Programming, Department of Animal Science, University of Wyoming, Laramie, WY, United States of America

Abstract

Obesity during human pregnancy predisposes offspring to obesity and cardiovascular disease in postnatal life. In a sheep model of maternal overnutrition/obesity we have previously reported myocardial inflammation and fibrosis, as well as cardiac dysfunction in late term fetuses, in association with chronically elevated blood cortisol. Significant research has suggested a link between elevated glucocorticoid exposure in utero and hypertension and cardiovascular disease postnatally. Here we examined the effects of maternal obesity on myocardial inflammation and fibrosis of their adult offspring. Adult male offspring from control (CON) mothers fed 100% of National Research Council (NRC) recommendations (n = 6) and male offspring from obese mothers (MO) fed 150% NRC (n = 6), were put on a 12-week ad libitum feeding challenge then necropsied. At necropsy, plasma cortisol and left and right ventricular thickness were markedly increased (P<0.05) in adult male MO offspring. Myocardial collagen content and collagen-crosslinking were greater (P<0.05) in MO offspring compared to CON offspring in association with increased mRNA and protein expression of glucocorticoid receptors (GR). No group difference was found in myocardial mineralocorticoids receptor (MR) protein expression. Further, mRNA expression for the proinflammatory cytokines: cluster of differentiation (CD)-68, transforming growth factor (TGF)-β1, and tumor necrosis factor (TNF)-α were increased (P < 0.05), and protein expression of CD-68, TGF-β1, and TNF-α tended to increase (P<0.10) in MO vs. CON offspring. These data provide evidence for MO-induced programming of elevated plasma cortisol and myocardial inflammation and fibrosis in adult offspring potentially through increased GR.

Introduction

Obesity is considered a worldwide public health concern, with about one-third of adults in the US currently classified as obese [1]. Further, obesity rates of women during pregnancy are between 20% and 34% and are increasing [2]. Accumulating evidence suggests that MO predisposes offspring to major risk factors, including obesity, insulin resistance, and cardiovascular dysfunction [3, 4, 5]. Cardiovascular disease is the number one cause of death globally, with more than 17 million deaths reported annually [6]. MO induces cardiac ventricular hypertrophy, inflammation, and cardiomyocyte contractile dysfunction in their offspring [7, 8].

One feature of cardiovascular dysfunction induced by MO is cardiac remodeling; an accumulation of extra cellular matrix proteins such as collagen (fibrosis) between muscle fibers and vessels [9]. Fibrosis in heart tissue is regulated by metalloproteinases and their inhibitors [10] and may diminish cardiomyocyte contractile function and eventually lead to heart failure [11]. Studies have shown that obesity may lead to fibrosis in the hearts of rats and mice [12]. Data from our lab showed that MO in sheep induces fibrosis in the myocardium of their fetuses [13] leading to increased ventricular weight and wall thickness, as well as the inability to sustain high work levels in vitro [14]. However, whether MO programs increased fibrosis in the hearts of their adult offspring has not been evaluated.

Overnutrition during pregnancy expands lipid deposition around the fetal heart and leads to macrophage infiltration and up-regulation of pro-inflammatory cytokines which in turn induce cardiovascular dysfunction and metabolic syndrome phenotypes in the offspring [15, 16, 17]. Fibrosis is usually accompanied by a low-grade inflammatory response [18]. Studies have shown that MO induces inflammation [19, 20, 21] which has been demonstrated as a cause for myocardial fibrosis and hypertension in rats [22]. MO-induced myocardial fibrosis in the fetus was also associated with inflammation and upregulation of transforming growth factor-β (TGF-β) /p38 signaling pathway [13]. TGF-β promotes pathological fibrosis via activation of the Smad signaling pathway (NF-κB) [14]. MO is associated with elevated plasma cortisol in mid and late gestation fetuses and in their adult offspring [23, 24]. It is noteworthy that fibrosis and up-regulation of proinflammatory cytokines is also seen in the hearts of adult sheep offspring of nutrient restricted mothers [25]. Chronic exposure to cortisol can lead to hypertension and cardiovascular morbidity and mortality which are the main consequences of Cushing’s syndrome [26]. Glucocorticoids play important roles in diverse physiological processes such as; glucose metabolism, immune system function, and fetal heart development [27, 28]. Further, glucocorticoids have been widely used as anti-inflammatory drugs that can reduce morbidity and mortality in premature babies. However, long-term treatment with these steroids results in many complications including cardiovascular disorders [29]. Cortisol induces its action by binding to nuclear glucocorticoid receptors (GR) and mineralocorticoid receptors (MR), which act as transcription factors when bound to a ligand. Both GR and MR are widely expressed in the heart whereby continued activation of GR and MR by chronic exposure to glucocorticoids and can lead to fibrosis, hypertension, and diastolic dysfunction [30, 31]. The role of MR in inducing cardiac diastolic dysfunction, hypertension, and cardiac remodeling has been reported [32, 33].

The aim of this study was to investigate the effect of chronically elevated cortisol induced by MO on the heart of their adult male offspring. Based on the pathological changes seen in these animals, our hypothesis is that the chronic exposure to elevated cortisol, which is initiated in utero and later induced by ad libitum feeding in adulthood may have adverse effects in the cardiovascular system of adult offspring potentially through the stimulation of increased GR activity.

Materials and methods

Animals

Animals and procedures used in this project were approved by the University of Wyoming Animal Care and Use Committee. Ewes were assigned randomly to a control (CON, 100% of NRC recommendations) or obese (MO, 150% of NRC) diet from two months before conception to term. Singleton male lambs (n = 6/maternal dietary group) were penned together and fed only to NRC recommendations from weaning until 19 months of age, then placed on a 12-week ad libitum feeding challenge. At the end of the feeding challenge, 20 ml of blood was drawn by venipuncture, then immediately centrifuged at 2,500 RPM for 15 minutes at 4°C and plasma stored at -80°C until analyzed. Male lambs were euthanized with an overdose of sodium pentobarbital (Beuthanasia-D Special; Schering-Plough Animal Health, Union, NJ) and the heart was quickly removed. The whole heart was weighed and left and right ventricular free wall dissected and weighed. Digital calipers (Absolute, Digimatic Caliper,Mitutoyo) were used to measure ventricular thicknesses and recorded at 3 random sites across each ventricular wall excluding the papillary muscles and values averaged as previously described [34]. Samples of myocardium were then collected from the left and right ventricular free walls, snap frozen in liquid nitrogen, and stored at –80°C until utilized for collagen analyses and mRNA and protein quantification.

Cortisol assay

Plasma cortisol was determined in duplicate as previously described [35], using a commercial cortisol radioimmunoassay (RIA) kit with a sensitivity of 0.5 μg/dL (Siemens Healthcare Diagnostics, Deerfield, IL, USA). All cortisol measurements were completed in a single assay and the intra-assay coefficient of variation (CV) was 4.5%.

Collagen and pyridinoline cross-linking determinations

Approximately 100 mg of heart tissue was ground and dried in a convection oven at 60°C, thereafter, the sample was reweighed and hydrolyzed in 6 N HCl at 105°C for 16 h. After HCL digestion, sample was neutralized with NaOH. An aliquot was saved for pyridinoline cross-linking analysis. Collagen concentration (mg/g dry muscle weight) was calculated based on hydroxyproline equivalent as published previously in our laboratory [13]. Oxidation of hydroxyproline with 4-(Dimethylamino) benzaldehyde (DMAB) results in a colorimetric (560 nm) product, proportional to the hydroxyproline concentration present in the sample. The intra-assay coefficient of variation (CV) was 13.3%. Pyridinoline crosslinks concentration in the sample was measured with Metra Serum PYD EIA kits (Quidel, San Diego, CA) following the company’s protocol. The pyridinoline concentration was expressed as nmol/mg of dry muscle weight and the intra-assay coefficient of variation (CV) was 3.29%.

RNA extraction, cDNA synthesis, and quantitative PCR analysis

Total RNA from 150mg of each sample of myocardial tissue was extracted using Trizol reagent (ThermoFisher, Waltham, MA), then treated with DNase I to digest DNA from RNA and then purified by RNeasy mini column (QIAGEN Inc. Valencia, CA) to obtain high-quality RNA from the tissue according to the manufacturer’s instructions. The quality of extracted RNA were determined spectrophotometrically by measuring the OD260/280 ratio in a pH neutral buffer, an OD260/280 of 2.0 which indicates good quality RNA were achieved. RNA integrity was evaluated by gel electrophoresis. Two μg of RNA was reverse transcribed into cDNA using a cDNA synthesis kit (QuantiTect Reverse Transcription Kit, QIAGEN, Valencia, CA) according to the manufacturer’s instructions. Quantitative RT-PCR was performed using a Bio-Rad IQ5 Real-time-PCR Reaction System (Bio-Rad Laboratories Inc., Hercules, CA). Gene names and sequences of the primers used are listed in Table 1.

PCR conditions used are as follows: 20 s at 95°C, 20 s at 56°C and 20 s at 72°C for 35 cycles. The expression of each gene was determined after normalization with an expression of the house keeping gene GAPDH. This is widely used in qPCR as housekeeping gene. Although it is a metabolic enzyme, in our study no treatment effects on its expression was observed in the heart between the groups. The relative expression level (in fold) was measured by using the 2−(ΔΔCt) method [36].

Protein extraction and western blot analysis

Heart samples were pulverized in liquid nitrogen, 100 mg of each sample were homogenized using a polytron homogenizer (Kinematica, Bohemia, NY) with 1ml of 1x Laemmle buffer pH 6.8 and 1% protease inhibitor cocktail, (Promega, Madison.WI). Homogenates were then centrifuged and the supernatants boiled at 95°C for 5 minutes. Proteins extracts were collected after a 10-min centrifugation at 12,000 × g. Protein concentrations were determined using a NanoDrop 2000C spectrophotometer (Thermo Scientific, Wilmington, DE). Western blot assay was performed as previously published from our laboratory [37]. Briefly, ~50 μg of protein in loading buffer was separated by 10% SDS-PAGE gel and transferred to a nitrocellulose membrane. The membranes were blocked with (5% nonfat dry milk in Tris-buffered saline-Tween 20 buffer containing 150 mM NaCl, 10 mM Tris, pH 7.6, and 0.05% Tween 20) for 1 hr at room temperature. Membranes were probed with primary antibodies against the following proteins: GR (Ab2768), MR (Ab2774), 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) (Ab39364), hexose-6-phosphate dehydrogenase (H6PD) (Ab 84353), TNF-α (Ab106606), CD 68(Ab63896), purchased from Abcam Inc. (Cambridge, MA), and TGF-β1 (3711), purchased from Cell Signaling (Danvers, MA). All antibodies were diluted in 5% (wt/vol) nonfat milk, at 1:500 overnight at 4°C. Probed membranes were further incubated with a secondary antibody conjugated with horseradish peroxidase at 1:3,000; concentration was diluted in 2% (wt/vol) nonfat milk for 60 min at room temperature. Membranes were visualized using enhanced chemiluminescence (ECL) western blotting reagents and exposed to an X-ray film (MR; Kodak, Rochester, NY). The density of bands was quantified by using ImageJ. Band density was normalized according to the density of β-actin content (anti-β-actin, cat. no. 4790; Cell Signaling Technology, Danvers, MA).

Statistical analysis

Data were analyzed using the MIXED procedure of SAS (SAS Institute, Cary, NC) with treatment as main effect. Statistical significance (p < 0.05) was estimated by Student’s unpaired t-test. Prism (GraphPad Software Inc, La Jolla, CA) was used to make the graphs.

Data are presented as least square (LS) means ± SEM, and differences are considered significant at P ≤ 0.05, with a tendency at P < 0.1.

Results

Plasma cortisol and myocardial phenotype

At necropsy, plasma cortisol concentrations were higher in MO offspring than in CON offspring (6.16 ± 1.01 versus 3.3 ± 0.9 ng/ml, respectively; (P < 0.05). Both the left and right ventricular thickness were greater (P < 0.05) in adult male MO offspring than CON offspring; Fig 1A and 1B respectively. When both the left and right ventricular thickness corrected for heart weight, the results showed no significant differences (P > 0.05) in adult male MO offspring than CON offspring (0.032± 0.0014 versus 0.03± 0.0014 mm) and (0.0135± 0.0006 versus 0.012± 0.0006 mm, respectively. Collagen concentration in ventricular heart tissue was measured by determining hydroxyproline equivalents in the sample. Collagen content was greater in MO offspring than CON offspring (1.73 ± 0.10 versus 1.42 ± 0.07 μg/mg, respectively; (P < 0.05) Fig 2A. Collagen crosslinking as measured by determining pyridinoline concentration in the sample was also greater (P < 0.05) in the hearts of MO offspring compared to CON offspring; Fig 2B.

thumbnail
Fig 1.

Left ventricular wall thickness (panel A) and right ventricular wall thickness (panel B) of adult CON offspring (open bars) and adult MO offspring (solid bars). Data are presented as *LS Means ± SEM differ, (P < 0.05); n = 6/group, and analyzed by Student's t test.

https://doi.org/10.1371/journal.pone.0189977.g001

thumbnail
Fig 2.

Collagen concentrations (panel A) and collagen crosslinking (panel B), in ventricular tissue of adult offspring. Open bars are CON offspring and solid bars are MO offspring. *LS Means ± SEM differ, (P < 0.05); n = 6/group. Data are analyzed by Student's t test.

https://doi.org/10.1371/journal.pone.0189977.g002

Myocardial mRNA and protein expression

Cardiac GR mRNA and protein expression were greater in MO than CON offspring (P < 0.05) (Fig 3A and 3B). In contrast, cardiac MR protein expression was similar in CON and MO offspring (Fig 3C). No protein expression was detected for the enzyme 11β-HSD1 or its cofactor H6PD. However, no significant differences were observed in cardiac protein expression of 11β-HSD2 between the groups (Fig 3D).

thumbnail
Fig 3.

mRNA expression of GR (panel A), protein expression of GR (panel B), protein expression of MR (panel C), and protein expression of 11ß-HSD2 (panel D) in the myocardium of CON (open bars) and MO (solid bars) adult male offspring. *LS Means ± SEM differ, (P < 0.05). #LS Means ± SEM differ, (P < 0.1); n = 6/group. Data are analyzed by Student's t test.

https://doi.org/10.1371/journal.pone.0189977.g003

Myocardial expression of proinflammatory cytokines

CD68 is an important marker for tissue macrophages; myocardial mRNA expression of CD68 was greater in MO than CON offspring (P < 0.05) (Fig 4A). Further, protein expression of CD68 tended to be higher in cardiac tissue of MO vs. CON offspring (P < 0.10) (Fig 4B).Cardiac mRNA expression of TGF-β1 was greater (P < 0.05) in MO vs. CON offspring (Fig 4C). Protein expression of TGF-β1 also tended to be greater in MO vs. CON offspring (P < 0.10) (Fig 4D).Cardiac mRNA expression of TNF-α was greater (P < 0.05) in MO vs. CON offspring (Fig 4E). Protein expression of TNF-α also tended to be increased in MO vs. CON offspring (P < 0.10) (Fig 4F). In contrast, there were no differences (P > 0.10) found in cardiac mRNA of IL-6, CD14, TLR4, and IL-18 cytokine gene expression (Fig 5).

thumbnail
Fig 4.

mRNA expression of CD68 (panel A), protein expression of CD68 (panel B), mRNA gene expression of TGF-ß1 (panel C), protein expression of TGF-ß1 (panel D), mRNA gene expression of TNF-alpha (panel E), and protein expression of TNF-alpha (panel F), in the myocardium of CON (open bars) and MO (solid bars) adult male offspring. *LS Means ± SEM differ, (P < 0.05). #LS Means ± SEM tended to differ, (P < 0.1); n = 6/group. Data are analyzed by Student's t test.

https://doi.org/10.1371/journal.pone.0189977.g004

thumbnail
Fig 5.

mRNA expression of IL-6 (panel A), CD14 (panel B), TLR4 (panel C), and IL-18 (panel D), in myocardial samples of CON (open bars) and MO (solid bars) offspring; n = 6/group. Data are presented as *LS Means ± SEM differ, (P < 0.05); n = 6/group, and analyzed by Student's t test.

https://doi.org/10.1371/journal.pone.0189977.g005

Discussion

The 12 weeks ad libitum feeding challenge was incorporated in our protocol because our previous findings showed no differences in growth rate or adiposity when both MO and CON offspring are maintained together from weaning to maturity and only fed to control diet. Therefore, a second exposure to stressful condition (in this case ad libitum feeding challenge) is required during adulthood to elicit phenotypical differences in postnatal metabolism and body composition based on the two hit hypothesis [38].

In the present study, we have demonstrated that MO leads to programing of myocardial inflammation and fibrosis in adult male offspring. These pathologic changes were associated with elevated plasma cortisol levels and increased expression of GR in the heart. The results further demonstrate an increased collagen and collagen cross-linking and up-regulation of the proinflammatory cytokines CD68, TGF-β1, and TNF-α in myocardial tissue.

These data suggest that GR activation by cortisol may contribute to the associated pathologic changes seen in the heart muscle. Plasma cortisol concentration is determined by the activity of the HPA axis, MO induces an increase in hypothalamic-pituitary stimulation of cortisol synthesis and secretion by the adrenal of their adult offspring [23]. However, cortisol can also be generated in peripheral tissues such as liver and adipose tissues by the enzyme 11β-HSD1 which are known to convert cortisone to cortisol leading to local tissue cortisol excess [39]. We recently reported that cortisol concentrations are increased in the liver and blood of fetal and adult male MO offspring through increased 11β-HSD1 and its co-factor H6PDH in liver tissue [40, 41]. The present study shows that11β-HSD1 and H6PDH are very low in adult heart tissue. Previous studies have reported that the expression of 11β-HSD1 in the heart is low and that its presence may exacerbate pathological heart changes [42].

Thus the pathological changes seen in the heart of adult MO offspring may be due to elevated levels of circulatory plasma cortisol rather than the local production of cortisol within the heart itself. The activity 11β-HSD2 in the heart is also usually very low in physiological conditions, however, this may not be the case during pathological conditions such as hypoxia where both the activity and expression of 11β-HSD2 are increased [42], our results showed the presence of 11β-HSD2 in myocardial tissue but with no significant differences between the groups. The 11β-HSD2 enzyme is known to convert the active cortisol to inactive cortisone [42].Therefore, 11β-HSD2 presence in the heart may promote protective effect to the heart [43]. Both GR and MR are expressed in cardiomyocytes [44] and both receptors are able to bind to cortisol. Our results showed increased expression of GR but not MR in heart tissue of MO offspring. Sheep studies aimed to mimic maternal stress showed that fetal short exposure to cortisol (10 days) at 130 days of gestation showed increased left ventricular thickness and proliferation and apoptosis in the heart. These proliferative and apoptotic effects of cortisol were induced by MR and GR respectively, [45]. Apoptosis is gene regulated programmed cell death and can lead to fibrosis in different types of tissues, including the heart [46]. Sufficient cortisol concentration is required for fetal heart maturation by GR- cortisol action, disruption of GR signaling in cardiomyocytes of mice resulted in an immature dysfunctional heart [27]. Obese rats treated with the GR antagonist Mifepristone (RU486) had reduced left ventricular fibrosis, diastolic dysfunction, cardiac oxidative stress, and inflammation [47]. Moreover, rat cardiomyocytes, treated in vitro with Dexamethasone, led to increased cell size and up-regulation of the hypertrophic markers, and these changes were abolished by RU486 and GR gene knockdown [48]. However, blocking the activity of MR with the antagonist Eplerenone or MR gene knockdown did not inhibit Dexamethasone mediated cardiomyocyte hypertrophy in rats [48]. RU486 is a competitive antagonist, and binds to GR with 3- fold higher affinity than Dexamethasone and 18-fold higher affinity than cortisol [49]. Eplerenone is an aldosterone-MR antagonist widely used for hypertension and heart failure treatment [50]. Although there was no difference in the protein expression of MR in OB compared to CON offspring in our study, there is cumulating evidence linking MR-aldosterone activation to hypertension and heart failure [51].

Our study demonstrated increased collagen and collagen cross-linking and up-regulation of CD68, TGF-β1, and TNF-α in myocardial tissue of MO adult offspring. Previous findings in several animal models have demonstrated that MO led to inflammation and fibrosis in the hearts of offspring [13, 52, 53]. In humans, MO is linked to premature death in adult offspring due to cardiovascular disease, pregnant MO women have increased circulation of inflammatory cytokines, fatty acids, and insulin resistance, these may induces hypertension and myocardial fibrosis in adult offspring as seen in other animal models [54]. Further, accumulation of adipose tissue can induce production of proinflammatory cytokines [55, 56] leading to lipotoxicity which can alter cardiovascular function in adult offspring [57]. Spencer et al., [58] reported that increased recruitment of inflammatory cytokines and collagen accumulation in human adipose tissue increases with body mass index (BMI). Fibrosis is trigged by inflammation [59] and regulated by the TGF-β /p38 signaling pathway [60], which may negatively alter cardiac function [11].

The present findings are consistent with our previous observations showing that MO upregulates TGF-β expression leading to fibrosis in the fetal heart [13] and the enlargement of the left and right ventricular wall thickness during mid gestation [61]. Moreover, overexpression of TNF-α in transgenic mice led to myocarditis, production of nitric oxide, and heart failure [62, 63]. CD 68 is a marker of macrophage infiltration and its presence, along with TNF-α, in heart tissue during chronic heart failure in humans, has been reported [64]. No significant differences in gene expression of IL-6, IL-18, CD14, and TLR4 cytokines in the present study, although previous data from our lab showed that MO induced inflammation and cardiac morphometry in the fetal heart, and alteration of the expression of IL-6, IL-18, CD14, and TLR4 [65]. It appears that these alterations do not persist in heart of adult MO offspring. This study supports our hypothesis that the MO-induced cardiac inflammation and fibrosis seen during fetal development persists in the myocardium of adult offspring after ad libitum feeding challenge. Since most of maternal insults upon the fetus are associated with increased levels of glucocorticoids, thus, these finding have broader implications for understanding how exposure to elevated cortisol concentration affects offspring health, especially, on the cardiovascular development. Our findings further suggest a potential role of increased myocardial GR in inducing the observed pathological changes seen in the heart. Future functional studies might be needed to confirm whether these changes seen in the heart are mediated through GR by blocking the activity of GR using GR antagonists or inhibitors.

In conclusion, these data demonstrate that MO during ovine pregnancy elevates blood cortisol concentrations from the adrenal or other body tissues (i.e. liver) and may predispose adult male offspring to cardiac dysfunction due to up-regulation of proinflammatory cytokines and fibrosis.

Acknowledgments

The authors would like to thank the students of the Center for the Study of Fetal Programming for their assistance in animal care and data collection on the farm, and Mr. Adam Uthlaut and Robert Cordery-Cotter, DVM for animal care and management.

References

  1. 1. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of childhood and adult obesity in the United States, 2011–2012. JAMA. 2014; 311:806–814. pmid:24570244
  2. 2. Heslehurst N, Ells LJ, Simpson H, Batterham A, Wilkinson J, Summerbell CD. Trends in maternal obesity incidence rates, demographic predictors, and health inequalities in 36 821 women over a 15‐year period. BJOG: An International Journal of Obstetrics & Gynaecology. 2007 Feb 1; 114(2):187–94.
  3. 3. Khan IY, Dekou V, Douglas G, Jensen R, Hanson MA, Poston L, et al. A high-fat diet during rat pregnancy or suckling induces cardiovascular dysfunction in adult offspring. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 2005 Jan 1; 288(1):R127–33. pmid:15308487
  4. 4. Mingrone G, Manco M, Mora ME, Guidone C, Iaconelli A, Gniuli D, et al. Influence of maternal obesity on insulin sensitivity and secretion in offspring. Diabetes care. 2008 Sep 1; 31(9):1872–6. pmid:18535193
  5. 5. Samuelsson AM, Matthews PA, Argenton M, Christie MR, McConnell JM, Jansen EH, et al. Diet-induced obesity in female mice leads to offspring hyperphagia, adiposity, hypertension, and insulin resistance. Hypertension. 2008 Feb 1; 51(2):383–92. pmid:18086952
  6. 6. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al. Heart disease and stroke statistics-2015 update: a report from the American Heart Association (vol 131, pg e29, 2015). Circulation. 2015 Jun 16; 131(24):E535–.
  7. 7. Fernandez-Twinn DS, Blackmore HL, Siggens L, Giussani DA, Cross CM, Foo R, et al. The programming of cardiac hypertrophy in the offspring by maternal obesity is associated with hyperinsulinemia, AKT, ERK, and mTOR activation. Endocrinology. 2012 Oct 15; 153(12):5961–71. pmid:23070543
  8. 8. Ren J, Kelley RO. Cardiac health in women with metabolic syndrome: clinical aspects and pathophysiology. Obesity. 2009 Jun 1; 17(6):1114–23. pmid:19214173
  9. 9. Manabe I, Shindo T, Nagai R. Gene expression in fibroblasts and fibrosis. Circulation research. 2002 Dec 13; 91(12):1103–13. pmid:12480810
  10. 10. Pardo A, Selman M. Matrix metalloproteases in aberrant fibrotic tissue remodeling. Proceedings of the American Thoracic Society. 2006 Jun; 3(4):383–8. pmid:16738205
  11. 11. Pontén A, Folestad EB, Pietras K, Eriksson U. Platelet-derived growth factor D induces cardiac fibrosis and proliferation of vascular smooth muscle cells in heart-specific transgenic mice. Circulation research. 2005 Nov 11; 97(10):1036–45. pmid:16224065
  12. 12. Abel ED, Litwin SE, Sweeney G. Cardiac remodeling in obesity. Physiological reviews. 2008 Apr 1; 88(2):389–419. pmid:18391168
  13. 13. Huang Y, Yan X, Zhao JX, Zhu MJ, McCormick RJ, Ford SP, et al. Maternal obesity induces fibrosis in fetal myocardium of sheep. American Journal of Physiology-Endocrinology and Metabolism. 2010 Dec 1; 299(6):E968–75. pmid:20876759
  14. 14. Wang J, Ma H, Tong C, Zhang H, Lawlis GB, Li Y, et al. Overnutrition and maternal obesity in sheep pregnancy alter the JNK-IRS-1 signaling cascades and cardiac function in the fetal heart. The FASEB Journal. 2010 Jun 1; 24(6):2066–76. pmid:20110268
  15. 15. Mills JL, Troendle J, Conley MR, Carter T, Druschel CM. Maternal obesity and congenital heart defects: a population-based study. The American journal of clinical nutrition. 2010 Jun 1; 91(6):1543–9. pmid:20375192
  16. 16. Roberts VH, Frias AE, Grove KL. Impact of maternal obesity on fetal programming of cardiovascular disease. Physiology. 2015 May 1; 30(3):224–31. pmid:25933822
  17. 17. Segovia SA, Vickers MH, Gray C, Reynolds CM. Maternal obesity, inflammation, and developmental programming. BioMed research international. 2014 May 20; 2014.
  18. 18. Wynn TA, Ramalingam TR. Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nature medicine. 2012 Jul 1; 18(7):1028–40. pmid:22772564
  19. 19. Ingvorsen C, Brix S, Ozanne SE, Hellgren LI. The effect of maternal Inflammation on foetal programming of metabolic disease. Acta Physiologica. 2015 Aug 1; 214(4):440–9. pmid:26011013
  20. 20. Pantham P, Aye IL, Powell TL. Inflammation in maternal obesity and gestational diabetes mellitus. Placenta. 2015 Jul 31; 36(7):709–15. pmid:25972077
  21. 21. Ramsay JE, Ferrell WR, Crawford L, Wallace AM, Greer IA, Sattar N. Maternal obesity is associated with dysregulation of metabolic, vascular, and inflammatory pathways. The Journal of Clinical Endocrinology & Metabolism. 2002 Sep 1; 87(9):4231–7.
  22. 22. Kai H, Kuwahara F, Tokuda K, Imaizumi T. Diastolic dysfunction in hypertensive hearts: roles of perivascular inflammation and reactive myocardial fibrosis. Hypertension Research. 2005 Jun 1; 28(6):483–90. pmid:16231753
  23. 23. Long NM, Nathanielsz PW, Ford SP. The impact of maternal overnutrition and obesity on hypothalamic-pituitary-adrenal axis response of offspring to stress. Domestic animal endocrinology. 2012 May 31; 42(4):195–202. pmid:22264661
  24. 24. Tuersunjiang N, Odhiambo JF, Long NM, Shasa DR, Nathanielsz PW, Ford SP. Diet reduction to requirements in obese/overfed ewes from early gestation prevents glucose/insulin dysregulation and returns fetal adiposity and organ development to control levels. American Journal of Physiology-Endocrinology and Metabolism. 2013 Oct 1; 305(7):E868–78. pmid:23921140
  25. 25. Ge W, Hu N, George LA, Ford SP, Nathanielsz PW, Wang XM, et al. Maternal nutrient restriction predisposes ventricular remodeling in adult sheep offspring. The Journal of nutritional biochemistry. 2013 Jul 31; 24(7):1258–65. pmid:23333094
  26. 26. Etxabe JV, Vazquez JA. Morbidity and mortality in Cushing's disease: an epidemiological approach. Clinical endocrinology. 1994 Apr 1; 40(4):479–84. pmid:8187313
  27. 27. Rog-Zielinska EA, Thomson A, Kenyon CJ, Brownstein DG, Moran CM, Szumska D, et al. Glucocorticoid receptor is required for foetal heart maturation. Human molecular genetics. 2013 Aug 15; 22(16):3269–82. pmid:23595884
  28. 28. Zanchi NE, Felitti V, Nicastro H, Lorenzeti FM, Lancha AH. Glucocorticoids: extensive physiological actions modulated through multiple mechanisms of gene regulation. Journal of cellular physiology. 2010 Aug 1; 224(2):311–5. pmid:20432441
  29. 29. Souverein PC, Berard A, Van Staa TP, Cooper C, Egberts AC, Leufkens HG, et al. Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case–control study. Heart. 2004 Aug 1; 90(8):859–65. pmid:15253953
  30. 30. Hattori T, Murase T, Iwase E, Takahashi K, Ohtake M, Tsuboi K, et al. Glucocorticoid-induced hypertension and cardiac injury: effects of mineralocorticoid and glucocorticoid receptor antagonism. Nagoya journal of medical science. 2013. 75(1–2):81–92. pmid:23544271
  31. 31. Walker BR. Glucocorticoids and cardiovascular disease. European Journal of Endocrinology. 2007 Nov 1; 157(5):545–59. pmid:17984234
  32. 32. Ohtake M, Hattori T, Murase T, Takahashi K, Takatsu M, Ohtake M, et al. Glucocorticoids activate cardiac mineralocorticoid receptors in adrenalectomized Dahl salt-sensitive rats. Nagoya journal of medical science. 2014 Feb; 76(1–2):59. pmid:25129992
  33. 33. Reini SA, Dutta G, Wood CE, Keller-Wood M. Cardiac corticosteroid receptors mediate the enlargement of the ovine fetal heart induced by chronic increases in maternal cortisol. Journal of Endocrinology. 2008 Aug 1; 198(2):419–27. pmid:18495945
  34. 34. Long NM, Rule DC, Tuersunjiang N, Nathanielsz PW, Ford SP. Maternal obesity in sheep increases fatty acid synthesis, upregulates nutrient transporters, and increases adiposity in adult male offspring after a feeding challenge. PloS one. 2015 Apr 15; 10(4):e0122152. pmid:25875659
  35. 35. Ford SP, Zhang L, Zhu M, Miller MM, Smith DT, Hess BW, et al. Maternal obesity accelerates fetal pancreatic β-cell but not α-cell development in sheep: prenatal consequences. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 2009 Sep 1; 297(3):R835–43. pmid:19605766
  36. 36. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2− ΔΔCT method. Methods. 2001 Dec 1; 25(4):402–8. pmid:11846609
  37. 37. Zhu MJ, Ma Y, Long NM, Du M, Ford SP. Maternal obesity markedly increases placental fatty acid transporter expression and fetal blood triglycerides at midgestation in the ewe. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 2010 Nov 1; 299(5):R1224–31. pmid:20844260
  38. 38. Ford SP, Tuersunjiang N. Maternal obesity: how big an impact does it have on offspring prenatally and during postnatal life? Expert Review of Endocrinology & Metabolism. 2013 May.
  39. 39. Staab CA, Maser E. 11β-Hydroxysteroid dehydrogenase type 1 is an important regulator at the interface of obesity and inflammation. The Journal of steroid biochemistry and molecular biology. 2010 Mar 31; 119(1):56–72.
  40. 40. Ghnenis AB, Odhiambo JF, Smith AM, Nathanielsz PW, Ford SP. Maternal Obesity (MO) in Sheep Programs Liver Secretion of Cortisol and Upregulates Glucocorticoid Receptors and Pro-inflammatory Mediators in the Hearts of Adult Offspring. 2016. (Abstract # 13). Available on: http://www.ssr.org/sites/ssr.org/files/uploads/attachments/node/320/2016_ssr_abstracts.pdf.
  41. 41. Smith AM, Ghnenis AB, OdhiamboJF, Nathanielsz PW, Ford SP. Maternal obesity induces increased placental conversion of maternal cortisol to cortisone followed by increased conversion of this cortisone to cortisol by the fetal liver and perirenal fat. 2016. (Abstract # 15). Available on: http://www.ssr.org/sites/ssr.org/files/uploads/attachments/node/320/2016_ssr_abstracts.pdf.
  42. 42. Gray GA, White CI, Castellan RF, McSweeney SJ, Chapman KE. Getting to the heart of intracellular glucocorticoid regeneration: 11β-HSD1 in the myocardium. Journal of Molecular Endocrinology. 2017 Jan 1; 58(1):R1–3. pmid:27553202
  43. 43. Lombès M, Alfaidy N, Eugene E, Lessana A, Farman N, Bonvalet JP. Prerequisite for cardiac aldosterone action. Circulation. 1995 Jul 15; 92(2):175–82. pmid:7600648
  44. 44. Richardson RV, Batchen EJ, Denvir MA, Gray GA, Chapman KE. Cardiac GR and MR: from development to pathology. Trends in Endocrinology & Metabolism. 2016 Jan 31; 27(1):35–43.
  45. 45. Feng X, Reini SA, Richards E, Wood CE, Keller-Wood M. Cortisol stimulates proliferation and apoptosis in the late gestation fetal heart: differential effects of mineralocorticoid and glucocorticoid receptors. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 2013 Aug 15; 305(4):R343–50. pmid:23785077
  46. 46. Johnson A, DiPietro LA. Apoptosis and angiogenesis: an evolving mechanism for fibrosis. The FASEB Journal. 2013 Oct 1; 27(10):3893–901. pmid:23783074
  47. 47. Takeshita Y, Watanabe S, Hattori T, Nagasawa K, Matsuura N, Takahashi K, et al. Blockade of glucocorticoid receptors with RU486 attenuates cardiac damage and adipose tissue inflammation in a rat model of metabolic syndrome. Hypertension Research. 2015 Nov 1; 38(11):741–50. pmid:26155752
  48. 48. Ren R, Oakley RH, Cruz-Topete D, Cidlowski JA. Dual role for glucocorticoids in cardiomyocyte hypertrophy and apoptosis. Endocrinology. 2012 Sep 18; 153(11):5346–60. pmid:22989630
  49. 49. Johanssen S, Allolio B. Mifepristone (RU 486) in Cushing's syndrome. European Journal of Endocrinology. 2007 Nov 1; 157(5):561–9. pmid:17984235
  50. 50. Craft J. Eplerenone (Inspra), a new aldosterone antagonist for the treatment of systemic hypertension and heart failure. Baylor University Medical Center. Proceedings 2004 Apr 1 (Vol. 17, No. 2, p. 217). pmid:16200104
  51. 51. Garg R, Adler GK. Aldosterone and the mineralocorticoid receptor: risk factors for cardiometabolic disorders. Current hypertension reports. 2015 Jul 1; 17(7):1–8.
  52. 52. Maloyan A, Muralimanoharan S, Huffman S, Cox LA, Nathanielsz PW, Myatt L, et al. Identification and comparative analyses of myocardial miRNAs involved in the fetal response to maternal obesity. Physiological genomics. 2013 Oct 1; 45(19):889–900. pmid:23922128
  53. 53. Turdi S, Ge W, Hu N, Bradley KM, Wang X, Ren J. Interaction between maternal and postnatal high fat diet leads to a greater risk of myocardial dysfunction in offspring via enhanced lipotoxicity, IRS-1 serine phosphorylation and mitochondrial defects. Journal of molecular and cellular cardiology. 2013 Feb 28; 55:117–29. pmid:23266593
  54. 54. Reynolds RM, Allan KM, Raja EA, Bhattacharya S, McNeill G, Hannaford PC, et al. Maternal obesity during pregnancy and premature mortality from cardiovascular event in adult offspring: follow-up of 1 323 275 person years. Bmj. 2013 Aug 13; 347:f4539. pmid:23943697
  55. 55. Maury E, Ehala-Aleksejev K, Guiot Y, Detry R, Vandenhooft A, Brichard SM. Adipokines oversecreted by omental adipose tissue in human obesity. American Journal of Physiology-Endocrinology and Metabolism. 2007 Sep 1; 293(3):E656–65. pmid:17578888
  56. 56. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. The Journal of clinical investigation. 2003 Dec 15; 112(12):1821–30. pmid:14679177
  57. 57. Dong M, Zheng Q, Ford SP, Nathanielsz PW, Ren J. Maternal obesity, lipotoxicity and cardiovascular diseases in offspring. Journal of Molecular and Cellular Cardiology. 2013 Feb 28; 55:111–6. pmid:22982026
  58. 58. Spencer M, Yao-Borengasser A, Unal R, Rasouli N, Gurley CM, Zhu B, et al. Adipose tissue macrophages in insulin-resistant subjects are associated with collagen VI and fibrosis and demonstrate alternative activation. American Journal of Physiology-Endocrinology and Metabolism. 2010 Dec 1; 299(6):E1016–27. pmid:20841504
  59. 59. Kaya Z, Göser S, Buss SJ, Leuschner F, Öttl R, Li J, et al. Identification of cardiac troponin I sequence motifs leading to heart failure by induction of myocardial inflammation and fibrosis. Circulation. 2008 Nov 11; 118(20):2063–72. pmid:18955666
  60. 60. Decologne N, Kolb M, Margetts PJ, Menetrier F, Artur Y, Garrido C, et al. TGF-β1 induces progressive pleural scarring and subpleural fibrosis. The Journal of Immunology. 2007 Nov 1; 179(9):6043–51. pmid:17947678
  61. 61. Fan X, Turdi S, Ford SP, Hua Y, Nijland MJ, Zhu M, et al. Influence of gestational overfeeding on cardiac morphometry and hypertrophic protein markers in fetal sheep. The Journal of nutritional biochemistry. 2011 Jan 31; 22(1):30–7. pmid:20188535
  62. 62. Bryant D, Becker L, Richardson J, Shelton J, Franco F, Peshock R, et al. Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-α. Circulation. 1998 Apr 14; 97(14):1375–81. pmid:9577949
  63. 63. Kubota T, McTiernan CF, Frye CS, Slawson SE, Lemster BH, Koretsky AP, et al. Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-α. Circulation Research. 1997 Oct 1; 81(4):627–35. pmid:9314845
  64. 64. Devaux B, Scholz D, Hirche A, Klövekorn WP, Schaper J. Upregulation of cell adhesion molecules and the presence of low grade inflammation in human chronic heart failure. European Heart Journal. 1997 Mar 1; 18(3):470–9. pmid:9076385
  65. 65. Kandadi MR, Hua Y, Zhu M, Turdi S, Nathanielsz PW, Ford SP, et al. Influence of gestational overfeeding on myocardial proinflammatory mediators in fetal sheep heart. The Journal of nutritional biochemistry. 2013 Nov 30; 24(11):1982–90. pmid:24075902